You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

10 November 2016

Promising new device can detect viral load in under 30 minutes

Viral load testing could become more accessible to millions of people living with HIV in sub-Saharan Africa thanks to a new USB testing stick.

31 October 2016

Hope for people living with multi-drug resistant HIV

Phase III trials of the intravenous drug ibalizumab have been found to significantly reduce viral load in people living with HIV who do not respond to existing treatment.

25 October 2016

Understanding the barriers to circumcision in southern and eastern Africa

Despite a willingness of men to undergo voluntary medical male circumcision (VMMC) for HIV prevention benefits in sub-Saharan Africa, uptake is low with just 56% of the 20.8 million circumcisions by 2016 target met.

12 October 2016

Zimbabwe: Improved treatment coverage cuts TB rates

Expanding access to treatment for people living with HIV is shown to decrease tuberculosis (TB) incidence – but it is not the silver bullet.

07 October 2016

New cervical screening method could save women’s lives in low-income countries

Study in South Africa and Burkina Faso shows that simple HPV screening could help save lives in places with limited health infrastructure.

05 October 2016

Kenya leads the way in child-friendly TB treatment

Kenya becomes first country in the world to introduce child-friendly tuberculosis (TB) medicine. It is hoped that the roll-out of this medication will drastically reduce the number of child TB deaths in the country.

30 September 2016

10% of children living with HIV don’t develop AIDS because immune system ignores HIV

The natural ability of some children's immune systems to hold off attacking HIV, thus stopping diseases progression, may provide clues for future treatment.

20 September 2016

African nations, private donors and high-income countries rally together to raise $US 13 billion for the Global Fund

Nearly US$ 13 billion has been pledged to the Global Fund to Fight AIDS, Tuberculosis and Malaria, to accelerate the response to end these diseases over the next three years.

14 September 2016

Europe grants marketing approval of Truvada for use as PrEP

The European Commission has given pharmaceutical company, Gilead, the green light to market Truvada as pre-exposure prophylaxis (PrEP) across the region.